Sunzen Biotech Bhd (0148) — Cash Flow-to-Debt Ratio
Sunzen Biotech Bhd (0148) has a Cash Flow-to-Debt Ratio of 0.22x as of September 2023, meaning its operating cash flow of RM3.58 Million could theoretically repay 0% of its total liabilities (RM16.55 Million) in one year. See how much free cash does Sunzen Biotech Bhd generate to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Sunzen Biotech Bhd Cash Flow-to-Debt Ratio (2016–2023)
Historical debt coverage capacity for Sunzen Biotech Bhd across 8 annual periods. Also explore how fast is Sunzen Biotech Bhd growing its equity to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Sunzen Biotech Bhd (2016–2023)
Year-by-year debt coverage analysis for Sunzen Biotech Bhd. For market capitalisation and broader financial context, see Sunzen Biotech Bhd (0148) market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (MYR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2023 | 0.04x | RM819.39K | RM20.51 Million | ▲ +103.6% |
| 2022 | -1.10x | RM-32.06 Million | RM29.08 Million | ▼ -106.3% |
| 2021 | -0.53x | RM-16.36 Million | RM30.61 Million | ▼ -365.1% |
| 2020 | 0.20x | RM7.20 Million | RM35.73 Million | ▲ +167.5% |
| 2019 | -0.30x | RM-11.05 Million | RM36.96 Million | ▼ -198.6% |
| 2018 | -0.10x | RM-4.07 Million | RM40.63 Million | ▼ -149.0% |
| 2017 | 0.20x | RM4.02 Million | RM19.70 Million | ▲ +615.6% |
| 2016 | 0.03x | RM256.13K | RM8.98 Million | — |